HETEROCYCLIC COMPOUND
엔테로펩티다아제 저해 작용을 갖는 융합 헤테로시클릭 화합물, 및 상기 화합물의 비만, 당뇨병 등의 치료 또는 예방용 의약으로서의 용도가 제공된다. 구체적으로는, 식 (I) 로 나타내는 화합물 또는 이의 염:[식 중, 각 기호는 본원에서 정의한 바와 같음], 및 상기 화합물의 비만, 당뇨병 등의 치료 또는 예방용 의약으로서의 용도가 제공된다. A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medic...
Saved in:
| Main Authors | , , , , |
|---|---|
| Format | Patent |
| Language | English Korean |
| Published |
28.09.2016
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | 엔테로펩티다아제 저해 작용을 갖는 융합 헤테로시클릭 화합물, 및 상기 화합물의 비만, 당뇨병 등의 치료 또는 예방용 의약으로서의 용도가 제공된다. 구체적으로는, 식 (I) 로 나타내는 화합물 또는 이의 염:[식 중, 각 기호는 본원에서 정의한 바와 같음], 및 상기 화합물의 비만, 당뇨병 등의 치료 또는 예방용 의약으로서의 용도가 제공된다.
A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. Specifically, a compound represented by the following formula (I): wherein each symbol is as defined herein, or a salt thereof and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. |
|---|---|
| AbstractList | 엔테로펩티다아제 저해 작용을 갖는 융합 헤테로시클릭 화합물, 및 상기 화합물의 비만, 당뇨병 등의 치료 또는 예방용 의약으로서의 용도가 제공된다. 구체적으로는, 식 (I) 로 나타내는 화합물 또는 이의 염:[식 중, 각 기호는 본원에서 정의한 바와 같음], 및 상기 화합물의 비만, 당뇨병 등의 치료 또는 예방용 의약으로서의 용도가 제공된다.
A fused heterocyclic compound having an enteropeptidase inhibitory action and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. Specifically, a compound represented by the following formula (I): wherein each symbol is as defined herein, or a salt thereof and use of the compound as a medicament for treatment or prophylaxis of obesity, diabetes mellitus, etc., are provided. |
| Author | KIKUCHI FUMIAKI KAKEGAWA KEIKO NISHIKAWA YOICHI SASAKI MINORU IKEDA ZENICHI |
| Author_xml | – fullname: IKEDA ZENICHI – fullname: SASAKI MINORU – fullname: NISHIKAWA YOICHI – fullname: KIKUCHI FUMIAKI – fullname: KAKEGAWA KEIKO |
| BookMark | eNrjYmDJy89L5WQQ9XANcQ3yd4509vF0VnD29w3wD_Vz4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8d5BRgaGZgaGhsZGlpaOxsSpAgDsuyGd |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | 헤테로시클릭 화합물 |
| ExternalDocumentID | KR20160113299A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_KR20160113299A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 14:52:41 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Korean |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_KR20160113299A3 |
| Notes | Application Number: KR20167024873 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160928&DB=EPODOC&CC=KR&NR=20160113299A |
| ParticipantIDs | epo_espacenet_KR20160113299A |
| PublicationCentury | 2000 |
| PublicationDate | 20160928 |
| PublicationDateYYYYMMDD | 2016-09-28 |
| PublicationDate_xml | – month: 09 year: 2016 text: 20160928 day: 28 |
| PublicationDecade | 2010 |
| PublicationYear | 2016 |
| RelatedCompanies | TAKEDA PHARMACEUTICAL COMPANY LIMITED |
| RelatedCompanies_xml | – name: TAKEDA PHARMACEUTICAL COMPANY LIMITED |
| Score | 3.0271358 |
| Snippet | 엔테로펩티다아제 저해 작용을 갖는 융합 헤테로시클릭 화합물, 및 상기 화합물의 비만, 당뇨병 등의 치료 또는 예방용 의약으로서의 용도가 제공된다. 구체적으로는, 식 (I) 로 나타내는 화합물 또는 이의 염:[식 중, 각 기호는 본원에서 정의한 바와 같음], 및 상기 화합물의 비만,... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| Title | HETEROCYCLIC COMPOUND |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160928&DB=EPODOC&locale=&CC=KR&NR=20160113299A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSQSd-JGcaKJrkJiSqGtibpGsa2mWZK5rZJJmDGq_G6ckgTqKvn5mHqEmXhGmEUwMObC9MOBzQsvBhyMCc1QyML-XgMvrAsQglgt4bWWxflImUCjf3i3E1kUN2js2NDOwNLJQc3GydQ3wd_F3VnN2tvUOUvMLgsiBb1W3dGRmYAU1pEEn7buGOYH2pRQgVypuggxsAUDz8kqEGJiy84UZOJ1hd68JM3D4Qqe8gUxo7isWYRD1cAU2Pv2dI519PJ0VnP19A_xD_VxEGZTdXEOcPXSB5sfDvRPvHYTsGGMxBhZgRz9VgkHBLCnJ2DwxOc0sCdgqsDC3tLBMtTBPM0iyNEszTAY2cyQZZPCZJIVfWpqBC8QFrXUwspBhYCkpKk2VBVaoJUly4HAAAD43dUg |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebzokfUwdK34pdW5vkoYhLWzr7SelkPpWma0EUN1zFf9-kbrqnvYUcHEngcr9L7n4HcJsLxo8i12Uln-WyjnAhE4MhWdUrTeB3bcZEoBiEhjvRn6b30xa8r2thGp7Q74YckVtUwe29bu7rxf8jltXkVi7v2Cufmj84qWlJq-h4aChExZI1Mu04siIqUWp6iRQmv7Kmqzp53IFdJPh5BXh6Hom6lMWmU3EOYS_m-j7qI2i9zbvQoevea13YD1Zf3ny4sr7lMfRcm4PPiL5Qf0wHNAriaBJaPbhx7JS6Mtef_W0n85LNxWgn0OaBfnkKA4MxDeVFZTCOCjAimJQYVQojRjUsOMw5g_42TefbxdfQcdPAz_xx6F3AgRCJvAcV96Fdf36Vl9y51uyqOZMf4X94NQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HETEROCYCLIC+COMPOUND&rft.inventor=IKEDA+ZENICHI&rft.inventor=SASAKI+MINORU&rft.inventor=NISHIKAWA+YOICHI&rft.inventor=KIKUCHI+FUMIAKI&rft.inventor=KAKEGAWA+KEIKO&rft.date=2016-09-28&rft.externalDBID=A&rft.externalDocID=KR20160113299A |